Zealand Pharma downgraded at Wolfe on concerns over obesity drug tolerability

Investing.com Gold reports: Zealand Pharma downgraded at Wolfe on concerns over obesity drug tolerability. Full body text was unavailable at ingest time, so this brief is based on headline context.